Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter- Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
Aims: The primary aim of this retrospective study was to determine the proportion of patients with myocardial infarction (MI) who fulfil the criteria of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II and the implications of MADIT II criteria in practice. Methods: We performed...
Main Authors: | Zia I Carrim, Ashraf A Khan, Shazad Aslam |
---|---|
Format: | Article |
Language: | English |
Published: |
McGill University
2020-12-01
|
Series: | McGill Journal of Medicine |
Subjects: | |
Online Access: | https://mjm.mcgill.ca/article/view/745 |
Similar Items
-
Beyond MADIT
by: Peerawut Deeprasertkul, et al.
Published: (2013-12-01) -
The prediction of ICD therapy in multicenter automatic defibrillator implantation trial (MADIT) II like patients: a retrospective analysis
by: Marco Budeus, et al.
Published: (2008-04-01) -
Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
by: Hans Römers, MSc, et al.
Published: (2023-01-01) -
Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01) -
Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
by: Valentino Ducceschi, et al.
Published: (2022-06-01)